Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States. It is testing Lumateperone Long-Acting Injectable Formulations for schizophrenia.
Multiple locations, including Los Alamitos
This study has public registry information in the United States. It is testing Multiple Rising Doses of TAK-137 for ADHD.
In MarltonThis study is completed in the United States. It focuses on Schizophrenia.
Multiple locations, including Long BeachThis study is completed in the United States. It is testing elpipodect for schizophrenia.
Multiple locations, including RogersThis study is completed in the United States. It is testing SPD489 for ADHD.
Multiple locations, including Newport BeachThis study is completed in the United States. It focuses on ADHD.
In Kansas CityThis study is active but not recruiting. It focuses on mental health and currently lists study information in Denmark.
In Hellerup
This study is enrolling by invitation. It focuses on depression and currently lists participation information in Switzerland.
In GenevaThis study is completed. It focuses on schizophrenia and currently lists study information in the United States.
In BaltimoreThis study has public registry information. It focuses on bipolarity and currently lists study information in Italy.
Multiple locations, including OrbetelloThis study is ongoing in Netherlands. It focuses on depression.
In NetherlandsThis study is completed. It focuses on bipolarity and currently lists study information in the United States.
In Mason